Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis

Recruiting now

Conditions studied: Psoriasis (PsO), Vitiligo Vulgaris, Atopic Dermatitis, Areata Alopecia

In brief

Primary objective: The primary objective is to evaluate in the general population the difference between emotional reactions associated with facial involvement by four major dermatologic diseases: psoriasis, atopic dermatitis, vitiligo, and alopecia areata. * Compare the social distance and stereotyping by the general population toward individuals with facial involvement by: psoriasis, atopic dermatitis, vitiligo, and alopecia areata. * Evaluate demographic factors that describe a greater tendency toward stigmatization.

Key facts

Study ID

NCT06801821

Run by

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

People needed

400

Starts

2025-02-01

Expected to finish

2026-03-01

Last updated by the study team

2025-08-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• -Patients aged>18 years, both sexes;
• Signature of written informed consent;

You may not qualify if…

• Patients diagnosed with psoriasis, atopic dermatitis, vitiligo or alopecia areata.
• Patients with first-degree relatives with psoriasis, atopic dermatitis, vitiligo or alopecia areata
• Those who for professional or personal reasons have direct knowledge of the diseases in question.

Where it is running

• Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Dermatologia — Roma, Italia, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.